Income Statement QHSLab, Inc.

Stocks

USAQ

US90350R1077

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 13:00:41 2026-05-29 EDT			5-day change	1st Jan Change
0.5000 ^USD	-24.24%		+42.86%	-17.48%

08-12	QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-14	QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

7368b723a5455c80833dc0f01.mKuoqFqnT0jsQ7kAMNkpFv1YGcF2N8qX6dUPUToQFHk.7OrL5zzsCALcbsBQSKgaQswrXpsMdp3mh6NZZGMjcU_M2vvhFtB5IZoT4A

Published financial data: QHSLAB, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	1.41M	1.24M	1.41M	2.13M	2.69M
Total Revenues	1.41M	1.24M	1.41M	2.13M	2.69M
Cost of Goods Sold, Total	744K	624K	615K	774K	881K
Gross Profit	671K	620K	794K	1.36M	1.81M
Selling General & Admin Expenses, Total	1.05M	918K	748K	786K	1.12M
R&D Expenses	90.87K	190K	214K	294K	485K
Amortization of Goodwill and Intangible Assets - (IS)	36.06K	72.11K	72.11K	72.11K	72.11K
Other Operating Expenses, Total	1.17M	1.18M	1.03M	1.15M	1.68M
Operating Income	-502K	-561K	-240K	206K	131K
Interest Expense, Total	-246K	-433K	-230K	-465K	-237K
Net Interest Expenses	-246K	-433K	-230K	-465K	-237K
Other Non Operating Income (Expenses)	-	-	2.29K	78	-102K
EBT, Excl. Unusual Items	-749K	-994K	-468K	-259K	-208K
Other Unusual Items	-21.43K	-2.02K	-	-	666K
EBT, Incl. Unusual Items	-770K	-996K	-468K	-259K	457K
Earnings From Continuing Operations	-770K	-996K	-468K	-259K	457K
Net Income to Company	-770K	-996K	-468K	-259K	457K
Net Income - (IS)	-770K	-996K	-468K	-259K	457K
Net Income to Common Incl Extra Items	-770K	-996K	-468K	-259K	457K
Net Income to Common Excl. Extra Items	-770K	-996K	-468K	-259K	457K
Per Share Items
Net EPS - Basic	-0.1	-0.11	-0.05	-0.03	0.04
Basic EPS - Continuing Operations	-0.1	-0.11	-0.05	-0.03	0.04
Basic Weighted Average Shares Outstanding	7.86M	9M	9.42M	10.29M	11.3M
Net EPS - Diluted	-0.1	-0.11	-0.05	-0.03	0.02
Diluted EPS - Continuing Operations	-0.1	-0.11	-0.05	-0.03	0.02
Diluted Weighted Average Shares Outstanding	7.86M	9M	9.42M	10.29M	19.34M
Normalized Basic EPS	-0.06	-0.07	-0.03	-0.02	-0.01
Normalized Diluted EPS	-0.06	-0.07	-0.03	-0.02	-0.01
Supplemental Items
EBITDA	-466K	-488K	-168K	278K	203K
EBITA	-466K	-488K	-168K	278K	203K
EBIT	-502K	-561K	-240K	206K	131K
Normalized Net Income	-468K	-621K	-293K	-162K	-130K
Interest on Long-Term Debt	246K	433K	-	-	-
Supplemental Operating Expense Items
Marketing Expenses	494K	-	-	-	-
Selling and Marketing Expenses	592K	530K	489K	509K	683K
General and Administrative Expenses	454K	388K	259K	276K	439K
Research And Development Expense From Footnotes	90.87K	246K	288K	369K	503K
Stock-Based Comp., R&D Exp. (Total)	64.71K	30.08K	6K	1.26K	7.55K
Stock-Based Comp., S&M Exp. (Total)	98.33K	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	71.45K	6.97K	-	-	19.25K
Stock-Based Comp., Other (Total)	-	-	-	13.84K	-
Total Stock-Based Compensation	234K	37.05K	6K	15.1K	26.8K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	287K	179K	51.58K	157K	636K
Total Cash And Short Term Investments	287K	179K	51.58K	157K	636K
Accounts Receivable, Total	70.47K	47.73K	71.38K	196K	191K
Total Receivables	70.47K	47.73K	71.38K	196K	191K
Inventory	65.74K	51.84K	25.18K	41.78K	35.79K
Prepaid Expenses	22.71K	7.31K	7.99K	25.79K	20.45K
Total Current Assets	446K	286K	156K	421K	883K
Other Intangibles, Total	1.76M	1.67M	1.53M	1.38M	1.29M
Total Assets	2.21M	1.96M	1.68M	1.8M	2.17M
Liabilities
Accounts Payable, Total	20.37K	85.74K	78.91K	341K	326K
Accrued Expenses, Total	-	-	26.52K	36.55K	-
Short-term Borrowings	-	440K	440K	476K	91.08K
Current Portion of Long-Term Debt	796K	1.06M	1.34M	1.26M	106K
Other Current Liabilities	58.62K	117K	170K	294K	-73.23K
Total Current Liabilities	875K	1.71M	2.06M	2.41M	450K
Long-Term Debt	503K	174K	-	-	96.22K
Other Non Current Liabilities	6.52K	-	-	-	-
Total Liabilities	1.38M	1.88M	2.06M	2.41M	546K
Preferred Stock Convertible	372	372	372	372	372
Total Preferred Equity	372	372	372	372	372
Common Stock, Total	876	932	974	1.08K	1.5K
Additional Paid In Capital	3.35M	3.59M	3.61M	3.72M	5.53M
Retained Earnings	-2.52M	-3.51M	-3.98M	-4.33M	-3.9M
Comprehensive Income and Other	-6.97K	-	-	-	-
Total Common Equity	824K	75.87K	-376K	-608K	1.62M
Total Equity	824K	76.24K	-376K	-608K	1.62M
Total Liabilities And Equity	2.21M	1.96M	1.68M	1.8M	2.17M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	8.82M	9.32M	10.22M	11.28M	15.03M
ECS Total Common Shares Outstanding	8.76M	9.32M	9.74M	10.81M	15.03M
Book Value / Share	0.09	0.01	-0.04	-0.06	0.11
Tangible Book Value	-939K	-1.6M	-1.9M	-1.99M	337K
Tangible Book Value Per Share	-0.11	-0.17	-0.2	-0.18	0.02
Total Debt	1.3M	1.68M	1.78M	1.74M	293K
Net Debt	1.01M	1.5M	1.73M	1.58M	-343K
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Finished Goods, Total	65.74K	51.84K	25.18K	41.78K	35.79K
Full Time Employees	5	4	4	4	12
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	8.23K	18.44K	22.72K	30K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-770K	-996K	-468K	-259K	457K
Amortization of Goodwill and Intangible Assets - (CF)	36.06K	72.11K	72.11K	72.11K	72.11K
Depreciation & Amortization, Total	36.06K	72.11K	72.11K	72.11K	72.11K
Amortization of Deferred Charges, Total - (CF)	154K	362K	159K	74.46K	18.62K
Stock-Based Compensation (CF)	234K	37.05K	6K	15.1K	21K
Provision and Write-off of Bad Debts	-	8.23K	10.22K	4.28K	7.28K
Other Operating Activities, Total	21.43K	2.02K	-	-	-564K
Change In Accounts Receivable	-9.95K	14.51K	-33.86K	-129K	-1.8K
Change In Inventories	33.96K	13.9K	26.66K	-16.6K	5.99K
Change In Accounts Payable	-125K	65.37K	-6.84K	262K	-14.53K
Change in Other Net Operating Assets	70.62K	69.97K	75.9K	119K	176K
Cash from Operations	-355K	-351K	-160K	142K	178K
Sale (Purchase) of Intangible assets	-155K	-37.12K	-	-	-
Cash from Investing	-155K	-37.12K	-	-	-
Short Term Debt Issued, Total	-	-	3.24K	10.3K	90.97K
Long-Term Debt Issued, Total	936K	640K	389K	146K	114K
Total Debt Issued	936K	640K	392K	157K	205K
Short Term Debt Repaid, Total	-	-	-	-	-14.5K
Long-Term Debt Repaid, Total	-179K	-380K	-359K	-194K	-390K
Total Debt Repaid	-179K	-380K	-359K	-194K	-404K
Issuance of Common Stock	30K	50K	-	-	500K
Other Financing Activities, Total	-85K	-30K	-	-	-
Cash from Financing	702K	280K	32.52K	-36.85K	301K
Net Change in Cash	193K	-108K	-127K	106K	479K
Supplemental Items
Cash Interest Paid	43.02K	71.78K	61.3K	246K	80.71K
Levered Free Cash Flow	-266K	-11.78K	17.81K	240K	-350K
Unlevered Free Cash Flow	-266K	-46.87K	77.79K	530K	-202K
Change In Net Working Capital	67.74K	-176K	-75.31K	-240K	401K
Net Debt Issued / Repaid	757K	260K	32.52K	-36.85K	-199K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-25.05	-16.82	-8.25	7.39	4.13
Return on Total Capital	-29.26	-18.07	-9.5	10.14	5.39
Return On Equity %	-713.99	-221.26	312.9	52.72	89.94
Return on Common Equity	-715.58	-221.44	312.12	52.68	90
Margin Analysis
Gross Profit Margin %	47.42	49.83	56.32	63.69	67.27
SG&A Margin	73.96	73.83	53.06	36.85	41.71
EBITDA Margin %	-32.96	-39.29	-11.93	13.03	7.55
EBITA Margin %	-32.96	-39.29	-11.93	13.03	7.55
EBIT Margin %	-35.51	-45.09	-17.04	9.65	4.88
Income From Continuing Operations Margin %	-54.45	-80.12	-33.24	-12.16	16.99
Net Income Margin %	-54.45	-80.12	-33.24	-12.16	16.99
Net Avail. For Common Margin %	-54.45	-80.12	-33.24	-12.16	16.99
Normalized Net Income Margin	-33.09	-49.97	-20.78	-7.6	-4.84
Levered Free Cash Flow Margin	-18.8	-0.95	1.26	11.24	-13.01
Unlevered Free Cash Flow Margin	-18.78	-3.77	5.52	24.87	-7.5
Asset Turnover
Asset Turnover	1.13	0.6	0.77	1.22	1.36
Receivables Turnover (Average Receivables)	21.59	21.03	23.66	15.94	13.92
Inventory Turnover (Average Inventory)	8.99	10.61	15.98	23.12	22.71
Short Term Liquidity
Current Ratio	0.51	0.17	0.08	0.17	1.96
Quick Ratio	0.41	0.13	0.06	0.15	1.84
Operating Cash Flow to Current Liabilities	-0.41	-0.21	-0.08	0.06	0.4
Days Sales Outstanding (Average Receivables)	16.9	17.35	15.43	22.96	26.22
Days Outstanding Inventory (Average Inventory)	40.6	34.41	22.84	15.83	16.07
Average Days Payable Outstanding	42.63	31.76	51.04	97.18	139.21
Cash Conversion Cycle (Average Days)	14.87	20	-12.77	-58.39	-96.93
Long Term Solvency
Total Debt/Equity	157.62	2.2K	-474.3	-285.63	18.02
Total Debt / Total Capital	61.18	95.66	126.72	153.87	15.27
LT Debt/Equity	61.03	228.71	-	-	5.92
Long-Term Debt / Total Capital	23.69	9.94	-	-	5.02
Total Liabilities / Total Assets	62.69	96.1	122.34	133.77	25.15
EBIT / Interest Expense	-2.04	-1.29	-1.04	0.44	0.55
EBITDA / Interest Expense	-1.89	-1.13	-0.73	0.6	0.86
(EBITDA - Capex) / Interest Expense	-1.89	-1.13	-0.73	0.6	0.86
Total Debt / EBITDA	-2.79	-3.44	-10.6	6.25	1.44
Net Debt / EBITDA	-2.17	-3.07	-10.29	5.68	-1.69
Total Debt / (EBITDA - Capex)	-2.79	-3.44	-10.6	6.25	1.44
Net Debt / (EBITDA - Capex)	-2.17	-3.07	-10.29	5.68	-1.69
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.04K	-12.11	13.34	51.31	26.26
Gross Profit, 1 Yr. Growth %	1.24K	-7.64	28.1	71.1	33.36
EBITDA, 1 Yr. Growth %	-	4.77	-65.59	-265.34	-26.81
EBITA, 1 Yr. Growth %	69.46	4.77	-65.59	-265.34	-26.81
EBIT, 1 Yr. Growth %	82.57	11.6	-57.16	-185.67	-36.21
Earnings From Cont. Operations, 1 Yr. Growth %	135.25	29.32	-52.98	-44.65	-276.45
Net Income, 1 Yr. Growth %	135.25	29.32	-52.98	-44.65	-276.45
Normalized Net Income, 1 Yr. Growth %	144.62	32.75	-52.88	-44.65	-19.63
Diluted EPS Before Extra, 1 Yr. Growth %	85.55	12.99	-55.07	-40	-166.66
Accounts Receivable, 1 Yr. Growth %	16.44	-32.27	49.54	174.7	-2.79
Inventory, 1 Yr. Growth %	-34.06	-21.14	-51.43	65.91	-14.34
Total Assets, 1 Yr. Growth %	641.45	-11.37	-14.1	7.02	20.64
Tangible Book Value, 1 Yr. Growth %	46.69	69.96	19.13	4.5	-116.94
Common Equity, 1 Yr. Growth %	-235.38	-90.79	-595.55	61.74	-367.14
Cash From Operations, 1 Yr. Growth %	114.26	-1.06	-54.52	-189.23	25.05
Levered Free Cash Flow, 1 Yr. Growth %	154.29	-95.57	-251.28	1.54K	-255.11
Unlevered Free Cash Flow, 1 Yr. Growth %	211.89	-82.36	-265.97	611.25	-139.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	215.96	-0.19	30.95	38.22
Gross Profit, 2 Yr. CAGR %	-	251.67	8.77	48.05	51.06
EBITDA, 2 Yr. CAGR %	-	-	-39.96	-24.58	10.01
EBITA, 2 Yr. CAGR %	73.93	33.24	-39.96	-24.58	10.01
EBIT, 2 Yr. CAGR %	80.54	42.74	-30.85	-39.42	-26.08
Earnings From Cont. Operations, 2 Yr. CAGR %	115.06	74.42	-22.02	-48.98	-1.18
Net Income, 2 Yr. CAGR %	115.06	74.42	-22.02	-48.98	-1.18
Normalized Net Income, 2 Yr. CAGR %	112.05	80.2	-20.91	-48.93	-33.3
Diluted EPS Before Extra, 2 Yr. CAGR %	78.42	44.8	-28.75	-47.94	-36.76
Accounts Receivable, 2 Yr. CAGR %	-	-11.19	0.64	102.68	63.41
Inventory, 2 Yr. CAGR %	-	-27.89	-38.11	-10.23	19.22
Total Assets, 2 Yr. CAGR %	815.67	156.35	-12.74	-4.12	13.63
Tangible Book Value, 2 Yr. CAGR %	47.79	57.9	42.29	11.57	-57.93
Common Equity, 2 Yr. CAGR %	38.42	-64.69	-32.44	183.11	107.86
Cash From Operations, 2 Yr. CAGR %	62.2	45.6	-32.92	-36.3	5.63
Levered Free Cash Flow, 2 Yr. CAGR %	21.45	-66.44	-74.11	351.09	390.14
Unlevered Free Cash Flow, 2 Yr. CAGR %	24.11	-25.82	-45.89	236.35	64.52
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	124.5	14.66	29.37
Gross Profit, 3 Yr. CAGR %	-	-	151.16	26.5	42.98
EBITDA, 3 Yr. CAGR %	-	-	-	-15.85	-25.33
EBITA, 3 Yr. CAGR %	157.27	46.89	-15.15	-15.85	-25.33
EBIT, 3 Yr. CAGR %	163.74	53.79	-4.43	-25.73	-38.37
Earnings From Cont. Operations, 3 Yr. CAGR %	171.16	81.52	12.68	-30.44	-22.85
Net Income, 3 Yr. CAGR %	171.16	81.52	12.68	-30.44	-22.85
Normalized Net Income, 3 Yr. CAGR %	168.62	81.4	15.23	-29.78	-40.6
Diluted EPS Before Extra, 3 Yr. CAGR %	108.82	53.22	-1.97	-32.6	-43.47
Accounts Receivable, 3 Yr. CAGR %	-	-	5.66	40.65	58.65
Inventory, 3 Yr. CAGR %	-	-	-36.79	-14.02	-11.62
Total Assets, 3 Yr. CAGR %	980.65	320.43	78.06	-6.6	3.51
Tangible Book Value, 3 Yr. CAGR %	20.74	54.84	43.74	28.38	-40.48
Common Equity, 3 Yr. CAGR %	15.58	-43.91	-14.82	-9.62	177.68
Cash From Operations, 3 Yr. CAGR %	107.8	37.56	-1.21	-26.23	-20.24
Levered Free Cash Flow, 3 Yr. CAGR %	-	-59.72	-44.56	-3.41	209.82
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-35.23	-2.98	25.91	62.68
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	84.91
Gross Profit, 5 Yr. CAGR %	-	-	-	-	104.94
EBITA, 5 Yr. CAGR %	108.03	441.4	43.75	12.51	-5.86
EBIT, 5 Yr. CAGR %	111.15	456.52	54.39	5.95	-13.76
Earnings From Cont. Operations, 5 Yr. CAGR %	101.39	144.68	64.71	9.26	6.92
Net Income, 5 Yr. CAGR %	101.39	144.68	64.71	9.26	6.92
Normalized Net Income, 5 Yr. CAGR %	100.26	144.58	64.71	9.26	-7.41
Diluted EPS Before Extra, 5 Yr. CAGR %	77.57	103.6	35.82	-0.51	-17.65
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	25.79
Inventory, 5 Yr. CAGR %	-	-	-	-	-18.53
Total Assets, 5 Yr. CAGR %	-	-	294.94	132.76	48.77
Tangible Book Value, 5 Yr. CAGR %	14.2	26.39	28.94	35.82	-12.07
Common Equity, 5 Yr. CAGR %	11.24	-31.27	-6.76	7.18	21.7
Cash From Operations, 5 Yr. CAGR %	91.07	406.78	32.2	1.1	1.47
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	5.86	27.35
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	25.18	18.83